| Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial. | |
| Hecht, J. Randolph; Bang, Yung-Jue; Qin, Shukui; Chung, Hyun-Chul; Xu, Jian-Ming; Park, Joon Oh; Jeziorski, Krzysztof; Shparyk, Yaroslav; Hoff, Paulo M.; Sobrero, Alberto F. | |
| 2013 | |
| 卷号 | 31 |
| 期号 | 15 |
| 会议录 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0732-183X |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4891176 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Hecht, J. Randolph,Bang, Yung-Jue,Qin, Shukui,et al. Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial.[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论